RNA-seq reveals transcriptomic differences in circadian-related genes of the choroid plexus in a preclinical chronic migraine model
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Background
Migraine patients show choroid plexus (CP) changes, impairing the blood-CSF barrier. The CP regulates circadian rhythms, but links between CP circadian genes and migraine are unexplored.
Objective
This study examined CP circadian gene transcriptome changes in a chronic migraine rat model versus controls to identify migraine-related pathways.
Design
Chronic migraine model: Sprague Dawley rats (3 females, 3 males) received nitroglycerine (NTG) every other day for 9 days; controls (3 females, 3 males) got saline. CP from the 4th ventricle was collected 2 hours post-final injection for RNAseq.
Methods
Migraine Behavior: Von Frey hair tests on days 1, 5, and 9, pre- and 2 hours post-NTG/saline injection, assessed basal and NTG-induced pain thresholds.
RNAseq & Analysis: Differentially expressed genes (p < 0.05, fold change > 1) were identified. GO, KEGG, and Reactome enrichment analyses evaluated circadian gene expression changes.
Results
-
NTG group showed reduced basal and NTG-induced pain thresholds on days 1, 5, and 9.
-
Females had more upregulated genes ( MT2A , SLC7A11 ), males upregulated ZBTB16 , S100A8 . SLC7A11 , SCG2 , GRIA1 showed inverse regulation (up in females, down in males).
-
Circadian gene expression altered: 10 genes upregulated (e.g., SERPINE1, MAPK9, ATF4 ), 13 downregulated (e.g., PER2, DBP, EZH2 ). Sex-specific differences: females ( FBXL12, GPR157 ), males ( NKX2-1, ATF4, CLOCK ).
-
GO/KEGG analyses revealed significant enrichment of circadian rhythm-related pathways, insulin resistance, and inflammatory response processes, with sex-specific differences: females showed HIF-1 signaling and hemoglobin-related pathways, while males exhibited arachidonic acid and leukotriene production.
Conclusion
CP transcriptomics in the rat migraine model revealed sex-specific gene regulation, with females upregulating antioxidant genes (MT2A, SLC7A11) and males upregulating inflammatory factors (ZBTB16, S100A8), alongside circadian disruption (e.g., SERPINE1 upregulated, PER2 downregulated). Pathway analyses indicate enriched circadian rhythms, HIF-1 signaling (females), inflammatory processes (males), lipid metabolism (PPARα), and heme signaling, highlighting sex-specific and circadian targets for migraine therapy.
